Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Deloitte
McKinsey
McKesson
Johnson and Johnson
Boehringer Ingelheim
Daiichi Sankyo
UBS

Generated: May 21, 2018

DrugPatentWatch Database Preview

RENOGRAFIN-60 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Renografin-60, and when can generic versions of Renografin-60 launch?

Renografin-60 is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in RENOGRAFIN-60 is diatrizoate meglumine; diatrizoate sodium. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for RENOGRAFIN-60
Drug patent expirations by year for RENOGRAFIN-60
Pharmacology for RENOGRAFIN-60

US Patents and Regulatory Information for RENOGRAFIN-60

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco RENOGRAFIN-60 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
Cantor Fitzgerald
Fish and Richardson
Baxter
AstraZeneca
McKesson
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.